The drugmakers may skip asking the U.S. FDA for emergency-use authorization for its COVID-19 shot and instead pursue the more time-intensive application for a full-fledged license. Source


And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.